Decoding inflammation
Inflammation is one of the body’s most powerful defenses — and one of its greatest vulnerabilities. It helps to heal after injury and fight infections, yet when it lingers or misfires, it causes damage within the human body and contributes to many serious diseases, from autoimmune disorders to heart disease and cancer.
To understand and control inflammation requires seeing it as it happens: inside living human tissues, over time. Inflammation is not a single switch that turns on or off. It is a constantly changing process, shaped by thousands of signals between molecules, cells, and tissues. Today’s tools can measure parts of this process, but they rarely decode the full story of how inflammation starts, spreads, adapts, or goes wrong.
We are building a new way to study inflammation using instrumented tissues: engineered human tissue models that contain miniaturized devices to continuously measure, map and track inflammation as it unfolds in real time and space. When combined with frontier AI, these systems reveal inflammation in action, showing how complex networks of signals drive injury, healing, and disease, and ultimately provide the ability to influence inflammation.
Our goal is to transform the body’s response to inflammation from being reactive into something that is predictable and controllable. By creating detailed, predictive maps and models of inflammatory dynamics across tissues, our work aims to uncover the design rules that govern human biology and develop tools that can monitor and modulate inflammation before it causes harm — ultimately enabling a new kind of medicine that prevents disease by restoring the body’s balance.
Our focus areas:
- Live tissue omics — New technologies that map inflammation in living tissues and understand how immune cells behave at the molecular level. Paired with frontier AI, these tools help reveal where inflammation comes from and how it evolves over time.
- Continuous inflammation monitoring — Bioelectronic tools that can track immune activity in real time by sensing molecular signals. These technologies aim to make inflammation a measurable, monitorable part of everyday health, much like heart rate or blood pressure.
- Deep profiling of immune cell states — Cutting-edge, high-throughput technologies to study how immune cells shift between healthy and disease-causing states. Large datasets and AI models help uncover new strategies to prevent or reverse these harmful transitions.
- Virtual Immune System — A comprehensive, AI model that spans molecules, cells, and tissues to predict how the immune system behaves over space and time. The Virtual Immune System is an effort spanning all of Biohub’s scientific grand challenges that will enable simulating inflammation, testing ideas, and guiding real-world interventions.
“We have an incredible, multidisciplinary team that is creating fit-for-purpose tools to measure things that have never been measured before. With this capability in hand, we can develop powerful AI models to predict immune system function.” — Shana Kelley, president of bioengineering
News
-
Shana Kelley: 5 new ways to measure inflammation
With AI-integrated platforms to watch immune cells in action, we will be able to intervene in inflammation before it becomes disease, says Biohub’s president of bioengineering.
-
Axios: Zuckerberg and Chan bet AI can cure all disease
-
Associated Press: Zuckerberg, Chan shift bulk of philanthropy to science, focusing on AI and biology to curb disease
Explore more news
Research
-
GREmLN: A Cellular Regulatory Network-Aware Transcriptomics Foundation Model
Mingxuan Zhang, Vinay Swamy, Rowan Cassius, et al. (2025) | bioRxiv
-
The regulatory architecture of the primed pluripotent cell state
Li, B.I., Alvarez, M.J., Zhao, H. et al.(2025) | Nature Communications
-
Systems Human Immunology and AI: Immune Setpoint and Immune Health
Yona Lei, John Tsang (2025) | Annual Review of Immunology
Explore more research
Team leaders
-
Abdalla Abdrabou
Fellow, Functional Immungenomics
-
Aleksandra Baranczak
Vice President, Strategy and Partnerships, Chicago
-
Hope Burks
Team Lead, Tissue Models
-
Anthony Cesnik
Group Leader, Spatial Biology
-
Csaba Forró
Group Leader, Biomimetronics
-
Aly Azeem Khan
Senior Director, Artificial Intelligence
Investigator program
Our investigator and residency programs support research and collaborations by some of the best minds in science, medicine, engineering and technology.
Meet our investigators
Join us in our mission
We are a collaborative community of scientists, engineers, and AI and machine learning experts from across multiple fields who are passionate about tackling complex challenges and share a unified vision of a world without disease.
Open positions